These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36406681)

  • 1. Identification by genetic algorithm optimized back propagation artificial neural network and validation of a four-gene signature for diagnosis and prognosis of pancreatic cancer.
    Li Z; Ma Z; Zhou Q; Wang S; Yan Q; Zhuang H; Zhou Z; Liu C; Wu Z; Zhao J; Huang S; Zhang C; Hou B
    Heliyon; 2022 Nov; 8(11):e11321. PubMed ID: 36406681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
    Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
    EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning identifies SLC6A14 as a novel biomarker promoting the proliferation and metastasis of pancreatic cancer via Wnt/β-catenin signaling.
    Dang C; Bian Q; Wang F; Wang H; Liang Z
    Sci Rep; 2024 Jan; 14(1):2116. PubMed ID: 38267509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.
    Li J; Ke J; Fang J; Chen JP
    J Cell Biochem; 2020 Jan; 121(1):743-754. PubMed ID: 31478239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Immune-Related Signatures Related to CD4+ T Cell Infiltration With Gene Co-Expression Network in Pancreatic Adenocarcinoma.
    Tan Z; Lei Y; Zhang B; Shi S; Liu J; Yu X; Xu J; Liang C
    Front Oncol; 2021; 11():674897. PubMed ID: 34367961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer.
    Chen Y; Xu R; Ruze R; Yang J; Wang H; Song J; You L; Wang C; Zhao Y
    Cancer Cell Int; 2021 Jun; 21(1):291. PubMed ID: 34090418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RankProd Combined with Genetic Algorithm Optimized Artificial Neural Network Establishes a Diagnostic and Prognostic Prediction Model that Revealed C1QTNF3 as a Biomarker for Prostate Cancer.
    Hou Q; Bing ZT; Hu C; Li MY; Yang KH; Mo Z; Xie XW; Liao JL; Lu Y; Horie S; Lou MW
    EBioMedicine; 2018 Jun; 32():234-244. PubMed ID: 29861410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel immunogenomic signature to predict prognosis and reveal immune infiltration characteristics in pancreatic ductal adenocarcinoma.
    Li A; Ye B; Lin F; Wang Y; Miao X; Jiang Y
    Precis Clin Med; 2022 Jun; 5(2):pbac010. PubMed ID: 35694712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
    Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
    Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying and Validating an Acidosis-Related Signature Associated with Prognosis and Tumor Immune Infiltration Characteristics in Pancreatic Carcinoma.
    Tang P; Qu W; Wu D; Chen S; Liu M; Chen W; Ai Q; Tang H; Zhou H
    J Immunol Res; 2021; 2021():3821055. PubMed ID: 34993253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
    Wu M; Li X; Zhang T; Liu Z; Zhao Y
    Front Oncol; 2019; 9():996. PubMed ID: 31612115
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases.
    Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y
    Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a tissue-based DNA methylation risk-score model to predict the prognosis of surgically resected pancreatic cancer patients.
    Yang J; Tang Y; Wang J; Yu C; Li H; Yi B; Li Y; Zhou J; Zhang Z
    Gland Surg; 2022 Oct; 11(10):1697-1711. PubMed ID: 36353587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma.
    Song W; He X; Gong P; Yang Y; Huang S; Zeng Y; Wei L; Zhang J
    Front Genet; 2021; 12():639246. PubMed ID: 34249078
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of hub genes correlated with the pathogenesis and prognosis in Pancreatic adenocarcinoma on bioinformatics methods.
    Shi LE; Shang X; Nie KC; Lin ZQ; Wang M; Huang YY; Zhu ZZ
    Transl Cancer Res; 2020 Aug; 9(8):4550-4562. PubMed ID: 35117820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer.
    Song J; Ruze R; Chen Y; Xu R; Yin X; Wang C; Xu Q; Zhao Y
    BMC Cancer; 2022 Aug; 22(1):894. PubMed ID: 35974300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of abnormal expression, prognostic value and oncogenic role of the hub gene FN1 in pancreatic ductal adenocarcinoma
    Lei X; Chen G; Li J; Wen W; Gong J; Fu J
    PeerJ; 2021; 9():e12141. PubMed ID: 34567847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Inflammatory Response Related Gene Signature Associated with Survival Outcome and Gemcitabine Response in Patients with Pancreatic Ductal Adenocarcinoma.
    Xiao Z; Li J; Yu Q; Zhou T; Duan J; Yang Z; Liu C; Xu F
    Front Pharmacol; 2021; 12():778294. PubMed ID: 35002712
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of a Novel Tumor Microenvironment-Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma.
    Ma C; Luo H; Cao J; Zheng X; Zhang J; Zhang Y; Fu Z
    Front Mol Biosci; 2020; 7():571641. PubMed ID: 33102522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.